OP-1 Augments Glucocorticoid-inhibited Fracture Healing in a Rat Fracture Model
AUTOR(ES)
Gilley, Robert S.
FONTE
Springer-Verlag
RESUMO
Glucocorticoids inhibit bone remodeling and fracture healing. We sought to determine whether osteogenic protein 1 (OP-1) can overcome this inhibition in a closed fracture model in the rat. Time-released prednisolone or placebo pellets were implanted subcutaneously; closed femoral fractures were created 2 weeks later in rats. Fractures received sham, OP-1 and collagen, or collagen-only implants. Femurs were harvested at 3, 10, 21, 28, and 42 days postfracture. Fractures were examined radiographically for amount of hard callus; mechanically for torque and stiffness (also expressed as a percentage of the contralateral intact femur); and histomorphometrically for amount of cartilaginous and noncartilaginous soft callus, hard callus, and total callus. Glucocorticoid administration inhibited fracture healing. The application of a devitalized Type I collagen matrix mitigated the inhibitory effects of prednisolone on fracture healing However, further increases in indices of fracture healing were observed when OP-1 was added to the collagen matrix compared with collagen alone. OP-1 and collagen was more effective than collagen alone.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2772924Documentos Relacionados
- Synthetic Alginate is a Carrier of OP-1 for Bone Induction
- OP-1 cDNA encodes an osteogenic protein in the TGF-beta family.
- The effects of alpha-tocopherol supplementation on fracture healing in a postmenopausal osteoporotic rat model
- Osteogenic Protein-1 Overcomes Inhibition of Fracture Healing in the Diabetic Rat: A Pilot Study
- Alloxan-induced diabetes delays repair in a rat model of closed tibial fracture
